2020
DOI: 10.1016/j.colsurfb.2020.110891
|View full text |Cite
|
Sign up to set email alerts
|

Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 146 publications
0
13
0
Order By: Relevance
“…Therefore, targeted miRNA delivery platforms that improve the homing of delivery vehicles to specific tissues are being explored. Active targeting has been achieved by tethering ligands, such as saccharides, vitamins, bisphosphonate, antibodies, peptides, and aptamers, to the delivery vehicles [167,168]. For example, chemical conjugation of folic acid, a vitamin, to bacteriophage pRNA-based delivery system enables specific recognition of folate receptors that are overexpressed on the surface of cancer cells but are barely detectable on normal tissues [169].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, targeted miRNA delivery platforms that improve the homing of delivery vehicles to specific tissues are being explored. Active targeting has been achieved by tethering ligands, such as saccharides, vitamins, bisphosphonate, antibodies, peptides, and aptamers, to the delivery vehicles [167,168]. For example, chemical conjugation of folic acid, a vitamin, to bacteriophage pRNA-based delivery system enables specific recognition of folate receptors that are overexpressed on the surface of cancer cells but are barely detectable on normal tissues [169].…”
Section: Discussionmentioning
confidence: 99%
“…Targeting may be classified into active and passive targeting. To enhance active targeting, functionalizing nanoparticles with ligands that lead to surface interaction with overexpressed surface molecule and proteins on cancer cells, thereby facilitating cellular uptake via receptor-mediated endocytosis (Huang et al, 2020). Figure 5 illustrates the internalization of nanocarriers by the cell through receptor-mediated endocytosis by use of a targeting ligand.…”
Section: Targeted Nanocarriers and Stimuli-responsive Nanocarriersmentioning
confidence: 99%
“…Despite advances of surgery and neoadjuvant chemotherapy during the past few decades, the overall survival rates of OS have reached a plateau [ 2 ]. However, these treatments still leave much to be improved, such as multi-drug resistance and severe side effects [ 3 ]. Therefore, there is an urgent need for the development of novel therapeutic strategies with high specificity and low toxicities to improve survival in patients with OS.…”
Section: Introductionmentioning
confidence: 99%